Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's disease and other degenerative disorders. Its lead drug candidate is COR388, an orally-administered brain-penetrating small molecule gingipain inhibitor, which has completed Phase 1a and Phase 1b clinical trials for use in patients with mild to moderate Alzheimer's disease. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
Market Cap | 82.599 Million | Shares Outstanding | 30.146 Million | Avg 30-day Volume | 411.687 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -0.73 |
Price to Revenue | 0.0 | Debt to Equity | 0.0 | EBITDA | -177.421 Million |
Price to Book Value | 1.7544 | Operating Margin | 0.0 | Enterprise Value | 75.935 Million |
Current Ratio | 9.923 | EPS Growth | -0.061 | Quick Ratio | 9.426 |
1 Yr BETA | 1.5129 | 52-week High/Low | 121.98 / 2.64 | Profit Margin | 0.0 |
Operating Cash Flow Growth | -21.9277 | Altman Z-Score | 4.1889 | Free Cash Flow to Firm | -72.16 Million |
Earnings Report | 2022-08-04 |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
|
0 | 2022-05-19 | 2 | |
THYE DIRK CHIEF EXECUTIVE OFFICER |
|
0 | 2022-05-19 | 2 |
SMITH KAREN L. CHIEF MEDICAL OFFICER |
|
0 | 2022-05-19 | 2 |
|
3,883,660 | 2022-05-19 | 2 | |
HANNAH BRENDAN CHIEF BUSINESS OFFICER |
|
0 | 2022-05-19 | 2 |
|
0 | 2022-03-14 | 2 | |
LOWE CHRISTOPHER P. INTERIM CEO, COO & CFO |
|
265,000 | 2022-03-03 | 6 |
MONOHON TED CHIEF ACCOUNTING OFFICER & VP |
|
34,000 | 2022-03-03 | 2 |
MCDOWELL CARYN GORDON CHIEF LEGAL & ADM. OFFICER |
|
140,000 | 2022-03-03 | 2 |
DETKE MICHAEL J. CHIEF MEDICAL OFFICER |
|
140,000 | 2022-03-03 | 4 |
HOLSINGER LESLIE EVP, PRECLINICAL DEVELOPMENT |
|
159,000 | 2022-03-03 | 2 |
LYNCH CASEY CHIEF EXECUTIVE OFFICER |
|
440,000 | 2022-01-03 | 2 |
DOMINY STEPHEN S. CHIEF SCIENTIFIC OFFICER |
|
125,000 | 2022-01-03 | 2 |
|
84,911 | 2021-10-08 | 4 | |
|
11,029 | 2021-06-16 | 1 | |
|
11,029 | 2021-06-16 | 1 | |
|
No longer subject to file | 2020-12-31 | 0 | |
|
0 | 2020-06-08 | 0 | |
|
No longer subject to file | 2020-06-03 | 0 | |
GAFRIC KRISTEN SVP, LEGAL & ADMINISTRATION |
|
0 | 2020-02-06 | 0 |
|
No longer subject to file | 2014-02-03 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-05-23 20:24:15 -0400 | 2022-05-23 | A | 1,365,449 | a | 1,365,449 | direct | ||||||||||
2022-05-23 20:29:04 -0400 | 2022-05-23 | A | 1,979,650 | a | 1,979,650 | direct | ||||||||||
2022-05-23 20:07:34 -0400 | 2022-05-23 | A | 353,656 | a | 353,656 | direct | ||||||||||
2022-05-23 20:29:04 -0400 | 2022-05-19 | A | 64,589 | a | 64,589 | direct | -3.5211 | 0.0 | 1 | -3.5211 | 2 | |||||
2022-05-23 20:07:34 -0400 | 2022-05-19 | A | 16,224 | a | 16,224 | direct | -3.5211 | 0.0 | 1 | -3.5211 | 2 | |||||
LAMOND DAVID - Director by david a. lamond trust dated 2006 |
2022-05-23 20:09:08 -0400 | 2022-05-19 | A | 200,002 | a | 1,734,722 | indirect | -3.5211 | 0.0 | 1 | -3.5211 | 2 | ||||
2022-05-23 20:17:43 -0400 | 2022-05-19 | A | 455,309 | a | 455,309 | direct | -3.5211 | 0.0 | 1 | -3.5211 | 2 | |||||
LOW PHILIP S - Director by philip s. low revocable trust |
2022-05-23 20:17:43 -0400 | 2022-05-19 | A | 63,974 | a | 63,974 | indirect | -3.5211 | 0.0 | 1 | -3.5211 | 2 | ||||
2022-05-23 20:24:15 -0400 | 2022-05-19 | A | 151,799 | a | 151,799 | direct | ||||||||||
2022-05-23 20:29:04 -0400 | 2022-05-19 | A | 206,391 | a | 206,391 | direct | ||||||||||
2022-05-23 20:07:34 -0400 | 2022-05-19 | A | 103,500 | a | 103,500 | direct | ||||||||||
2022-05-23 20:17:43 -0400 | 2022-05-19 | A | 22,058 | a | 22,058 | direct | ||||||||||
2022-05-23 20:24:15 -0400 | 2022-05-19 | A | 24,336 | a | 24,336 | direct | -3.5211 | 0.0 | 1 | -3.5211 | 2 |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
CORTEXYME INC CRTX | 2022-05-26 22:15:03 UTC | -3.7941 | 4.6141 | 450000 |
CORTEXYME INC CRTX | 2022-05-26 21:45:03 UTC | -3.7941 | 4.6141 | 450000 |
CORTEXYME INC CRTX | 2022-05-26 21:15:03 UTC | -3.7941 | 4.6141 | 450000 |
CORTEXYME INC CRTX | 2022-05-26 20:45:03 UTC | -3.7941 | 4.6141 | 450000 |
CORTEXYME INC CRTX | 2022-05-26 20:15:03 UTC | -3.7941 | 4.6141 | 450000 |
CORTEXYME INC CRTX | 2022-05-26 19:45:03 UTC | -3.7941 | 4.6141 | 450000 |
CORTEXYME INC CRTX | 2022-05-26 19:15:03 UTC | -3.7941 | 4.6141 | 450000 |
CORTEXYME INC CRTX | 2022-05-26 18:45:04 UTC | -3.7941 | 4.6141 | 450000 |
CORTEXYME INC CRTX | 2022-05-26 18:15:03 UTC | -3.7941 | 4.6141 | 450000 |
CORTEXYME INC CRTX | 2022-05-26 17:45:03 UTC | -3.7941 | 4.6141 | 450000 |
CORTEXYME INC CRTX | 2022-05-26 17:15:03 UTC | -3.7941 | 4.6141 | 450000 |
CORTEXYME INC CRTX | 2022-05-26 16:45:04 UTC | -3.7919 | 4.6119 | 450000 |
CORTEXYME INC CRTX | 2022-05-26 16:15:03 UTC | -3.7919 | 4.6119 | 450000 |
CORTEXYME INC CRTX | 2022-05-26 15:45:03 UTC | -3.7919 | 4.6119 | 450000 |
CORTEXYME INC CRTX | 2022-05-26 15:15:03 UTC | -3.7919 | 4.6119 | 300000 |
CORTEXYME INC CRTX | 2022-05-26 14:45:03 UTC | -3.6923 | 4.5123 | 300000 |
CORTEXYME INC CRTX | 2022-05-26 14:15:03 UTC | -3.6923 | 4.5123 | 300000 |
CORTEXYME INC CRTX | 2022-05-26 13:45:05 UTC | -3.6923 | 4.5123 | 300000 |
CORTEXYME INC CRTX | 2022-05-26 13:15:03 UTC | -3.6923 | 4.5123 | 300000 |
CORTEXYME INC CRTX | 2022-05-26 12:45:03 UTC | -3.6923 | 4.5123 | 300000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|